Holen Sie sich die Stockscreener-App
4.02
2.55%
0.10
Schlusskurs vom Vortag:
$3.92
Offen:
$3.89
24-Stunden-Volumen:
62,063
Relative Volume:
0.40
Marktkapitalisierung:
$17.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.75M
KGV:
-1.2369
EPS:
-3.25
Netto-Cashflow:
$-30.91M
1W Leistung:
+8.94%
1M Leistung:
+13.56%
6M Leistung:
+998.66%
1J Leistung:
+214.06%
1-Tages-Spanne:
$3.79
$4.05
1-Wochen-Bereich:
$3.61
$4.05
52-Wochen-Spanne:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Firmenname
Cellectar Biosciences Inc
Sektor
Branche
Telefon
(608) 441-8120
Adresse
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Vergleichen Sie CLRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.02 | 16.62M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2020-07-01 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-21 | Fortgesetzt | ROTH Capital | Buy |
| 2019-09-13 | Eingeleitet | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
Cellectar Biosciences (CLRB) price target decreased by 44.05% to 47.94 - MSN
Can Cellectar Biosciences Inc. (NV4) stock retain market dominance2025 Top Decliners & Proven Capital Preservation Methods - Newser
Will Cellectar Biosciences Inc. (NV4) stock deliver compounding returnsWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Will Cellectar Biosciences Inc. (NV4) stock maintain strong growthJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Is Cellectar Biosciences Inc. (NV4) stock supported by strong fundamentalsPrice Action & High Accuracy Trade Alerts - Newser
How reliable is Cellectar Biosciences Inc. (NV4) stock dividend growthDip Buying & Stock Portfolio Risk Management - Newser
Cellectar Biosciences (CLRB) Stock Analysis Report | Financials & Insights - Benzinga
Why retail investors pile into Cellectar Biosciences Inc. stockGap Down & Advanced Swing Trade Entry Alerts - Newser
Critical Analysis: Cellectar Biosciences (NASDAQ:CLRB) & Agilent Technologies (NYSE:A) - Defense World
How strong is Cellectar Biosciences Inc. (NV4) stock earnings growthEarnings Overview Summary & Weekly Top Stock Performers List - Newser
Is Cellectar Biosciences Inc. stock attractive for ETFs2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Cellectar Biosciences sees cash balance sufficient into 2Q25 - TipRanks
Is Cellectar Biosciences Inc. stock dividend yield sustainableQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - BỘ NỘI VỤ
What drives Cellectar Biosciences Inc stock priceResistance Zone Identification & Affordable Stock Picks - earlytimes.in
Will Cellectar Biosciences Inc. stock benefit from sector rotationJuly 2025 Volume & Long Hold Capital Preservation Tips - BỘ NỘI VỤ
Cellectar Biosciences Reports Q3 2025 Financial Progress - MSN
Is Cellectar Biosciences Inc. stock near bottom after decline2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
CLRB warrants resale, going concern warning and WM drug milestones - Stock Titan
Is Cellectar Biosciences Inc. (NV4) stock a top dividend aristocrat candidate2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Why Cellectar Biosciences Inc. stock could outperform in 2025Portfolio Value Report & Accurate Buy Signal Notifications - newser.com
Cellectar signals 2027 global launch for iopofosine as regulatory momentum accelerates - MSN
Using R and stats models for Cellectar Biosciences Inc. forecastingTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
How Cellectar Biosciences Inc. stock performs in stagflationEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Is Cellectar Biosciences Inc. (NV4) stock supported by free cash flowJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Will Cellectar Biosciences Inc. stock outperform tech sector in 2025Rate Cut & Weekly Chart Analysis and Trade Guides - newser.com
Will Cellectar Biosciences Inc. bounce back from current supportJuly 2025 Drop Watch & Capital Protection Trading Alerts - newser.com
Is Cellectar Biosciences Inc. stock a top pick in earnings seasonEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
How geopolitical tensions affect Cellectar Biosciences Inc. stock - newser.com
Can Cellectar Biosciences Inc. stock hit record highs againWeekly Trade Review & Capital Efficient Trading Techniques - newser.com
How hedge fund analytics apply to Cellectar Biosciences Inc. stockPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Is Cellectar Biosciences Inc. stock positioned for long term growthJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
What valuation ratios show for Cellectar Biosciences Inc. (NV4) stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Will Cellectar Biosciences Inc. (NV4) stock beat growth indexes2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Using RSI to spot recovery in Cellectar Biosciences Inc.July 2025 Action & Target Return Focused Picks - newser.com
Can Cellectar Biosciences Inc. hit a new high this monthInsider Selling & High Yield Stock Recommendations - newser.com
Is now a turning point for Cellectar Biosciences Inc.Trade Exit Summary & Weekly Breakout Watchlists - newser.com
Using data filters to optimize entry into Cellectar Biosciences Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
Is Cellectar Biosciences Inc. stock a bargain at current levelsWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):